About us...
SYMBYX Biome is an Australian med-tech company developing laser-light therapies (red and near-infrared) for previously intractable neurodegenerative, metabolic and endothelial function disorders. We focus primarily on treating the microbiome, a relatively new but powerful area of medicine with uncapped potential. Our scientists are amongst the first in the world to control many Parkinson’s symptoms (both cognitive and motor deficits). Our treatments are based on human clinical trials which were conducted at leading Australian hospitals and universities under then leadership of Dr Ann Liebert. They are also drug-free, non-invasive and without harmful side-effects. Our therapies should currently be considered as complementary to your existing treatments and always first consult with a qualified health care provider before any changes are made to your daily routine.
SYMBYX’ hand-held lasers, which are precision-engineered in Sweden, are high-quality medical devices. They are specifically designed for home-use and, in conjunction with our recommended dietary and daily exercise programs, maximise patient flexibility and convenience. Patient testimonials from around the world - including Australia, NZ, US, UK, Ireland, Spain, Latvia, South Africa and Israel - are extremely encouraging and we are inspired to expand our clinical trials and develop a new generation of patient-friendly devices.
